circulating angiogenic factor levels in hypertensive disorders of pregnancy

Circulating angiogenic factor levels in hypertensive disorders of pregnancy are typically correlated with the severity of the condition. These factors, including but not limited to Vascular Endothelial Growth Factor (VEGF) and Placental Growth Factor (PIGF), are essential for sustaining a healthy pregnancy. However, in cases of hypertensive disorders of pregnancy, alterations in these levels can impact the health of both the mother and the fetus.

In mild hypertensive disorders of pregnancy, VEGF levels may slightly increase as an adaptive response to hypoxia. As the disease advances and becomes more severe, VEGF levels may rise significantly, while PIGF levels may decrease. Such changes can lead to placental insufficiency, potentially affecting fetal growth and development.

For pregnant women with hypertensive disorders of pregnancy, regular monitoring of circulating angiogenic factor levels is crucial. This not only assists physicians in evaluating the severity of the condition but also informs clinical treatment decisions. Additionally, pregnant women should focus on diet and exercise, maintaining healthy lifestyle habits to mitigate the risk of disease. At all times, it is imperative to follow medical advice and not to self-administer medication without guidance. Should any discomfort arise, prompt medical consultation is advised.